⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4354057 | 0.78 | AOC3 (0.47) | — | |
| Sulfanilamide SCHEMBL27962185 | 0.77 | CA2 (0.46) | — | |
| SCHEMBL10033203 | 0.74 | — | — | |
| SCHEMBL18838245 | 0.74 | CYP17A1 (0.42) | — | |
| SCHEMBL907670 | 0.74 | KDM4E (0.43) | — | |
| SCHEMBL24729703 | 0.73 | — | — | |
| SCHEMBL8983616 | 0.73 | — | — | |
| SCHEMBL29919731 | 0.73 | — | — | |
| SCHEMBL25401159 | 0.73 | — | — | |
| SCHEMBL1359723 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6362335-B1 | — | — | None | — | — | US | claimed |
| CN-118812441-A | Industrial sulfanilamide production and preparation process | 安达裕顺化工有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-114948993-A | Preparation method and application of skin gel for treating tinea capitis, skin eczema and acne | 罗露曦 | 2022-08-30 | — | — | CN | claimed |
| EP-1289994-B1 | PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY 1,2,4]TRIAZOLO 1,5-c]PYRIMIDINE | DOW AGROSCIENCES LLC (US) | 2004-03-17 | — | — | EP | claimed |
| EP-1289994-A1 | PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY 1,2,4]TRIAZOLO 1,5-c]PYRIMIDINE | Dow AgroSciences LLC (US) | 2003-03-12 | — | — | EP | claimed |
| US-6362335-B2 | CONTACTING 3-AMINO-8-METHOXY(1,2,4) TRIAZOLO(4,3-C)PYRIMIDINE COMPOUNDS WITH SODIUM OR POTASSIUM METHOXIDE IN AN ALCOHOL SOLVENT | DOW AGROSCIENCES LLC | 2002-03-26 | — | — | US | claimed |
| US-20020013230-A1 | Process for the preparation of 2-amino-5, 8-dimethoxy (1,2,4) triazolo (1,5-c) pyrimidine | CORTEVA AGRISCIENCE LLC | 2002-01-31 | — | — | US | claimed |
| WO-2001098305-A1 | PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE | DOW AGROSCIENCES LLC (US) | 2001-12-27 | — | — | WO | claimed |
| US-6362335-B1 | — | — | None | — | — | US | disclosed |
| US-12612414-B2 | Nitrile SUMO inhibitors and uses thereof | CIT THERAPEUTICS, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260108527-A1 | POLO LIKE KINASE 4 INHIBITORS | ORIC PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260083851-A1 | POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| US-12570631-B2 | Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk | BIOGEN MA INC. (US) | 2026-03-10 | — | — | US | disclosed |
| CN-120987854-A | Preparation process of industrial sulfanilamide | 内蒙古博霖制药有限公司 | 2025-11-21 | — | — | CN | disclosed |
| CN-1085556-A | The 4-pyrimidyl and the pyridinyl derivatives of the indol-3-yl alkylpiperazine of anti-migraine | BRISTOL MYERS SQUIBB CO (US) | 1994-04-20 | — | — | CN | disclosed |
| US-5300506-A | Indole-3-alkyl derivatives of alkoxypyrimidinylpiperazines | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0548813-A1 | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines | Bristol-Myers Squibb Company (US) | 1993-06-30 | — | — | EP | disclosed |
| EP-0464604-A2 | 1-Indolylalkyl-4-(alkoxy-pyrimidinyl)piperazines | Bristol-Myers Squibb Company (US) | 1992-01-08 | — | — | EP | disclosed |
| EP-0464558-A1 | Antimigraine alkoxypyrimidine derivatives | Bristol-Myers Squibb Company (US) | 1992-01-08 | — | — | EP | disclosed |
| US-5077293-A | Antidepressants | BRISTOL-MYERS SQUIBB CO. (US) | 1991-12-31 | — | — | US | disclosed |